The Fentanyl Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Fentanyl Market:
https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report
In accordance with The Business Research Company’s Fentanyl Global Market Report 2024, the fentanyl market has demonstrated robust growth in recent years, surging from $15.14 billion in 2024 to $16.22 billion in 2024, indicating a notable compound annual growth rate (CAGR) of 7.2%. This growth trajectory in the historical period can be primarily attributed to the imperative demands in pain management, burgeoning medical procedures and surgeries, the exigency in cancer pain management, the upsurge in the opioid analgesic market, and the demographic shift towards an aging population.
Forecasts indicate a continued robust expansion in the fentanyl market size over the forthcoming years, with estimations projecting an escalation to $20.79 billion by 2028, boasting a CAGR of 6.4%. This anticipated growth in the forecast period is anticipated due to the escalation in chronic pain cases, the widening scope of oncology therapies, the escalating rate of surgical procedures, the impetus of public health initiatives, and the regulatory green lights for novel indications. Prominent trends anticipated in the forecast period encompass technological strides in drug formulations, innovations in detection methodologies, the promulgation of public health and harm reduction strategies, the surge in pharmaceutical applications, and the fostering of international collaboration coupled with information dissemination.
The increasing prevalence of chronic diseases is expected to propel the growth of the fentanyl market going forward. A chronic disease is a medical condition that persists over a long period, typically for three months or more, and often continues throughout a person’s life. Fentanyl is used in chronic diseases primarily to manage severe, persistent pain that other medications or interventions do not effectively control. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, each year, there are 41 million deaths globally caused by non-communicable diseases (NCDs), which accounts for 74% of all deaths worldwide. Further, in August 2024, according to the data published by the British Heart Foundation, a UK-based non-profit organization, the number of deaths caused by coronary heart disease in the UK increased to 65,579 in 2021, compared with 64,170 in 2020. Therefore, the increasing prevalence of chronic diseases is driving the growth of the fentanyl market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp
The fentanyl market covered in this report is segmented –
1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Top 5 Major Players:
Leading entities within the fentanyl market sphere are diligently pioneering innovative product lines such as Opvee, while securing necessary approvals to cater to burgeoning customer segments, augment sales figures, and bolster revenue streams. Opvee, a potent opioid receptor antagonist like nalmefene, has emerged as a vital solution in combating known or suspected opioid overdoses triggered by natural or synthetic opioids, notably fentanyl. Notably, in May 2024, Indivior PLC, a reputable US-based pharmaceutical entity, garnered the coveted U.S. Food and Drug Administration (FDA) approval for Opvee nasal spray. Functioning by impeding the neurological effects of opioids, Opvee offers critical assistance to patients encountering recent overdoses by reinstating normal respiration and blood pressure levels. Administered conveniently as a nasal spray, Opvee serves as an indispensable component within the arsenal of medications devised to counteract opioid overdoses and safeguard human lives.
The fentanyl market report table of contents includes:
1. Executive Summary
2. Fentanyl Market Characteristics
3. Fentanyl Market Trends And Strategies
4. Fentanyl Market – Macro Economic Scenario
5. Global Fentanyl Market Size and Growth
….
32. Global Fentanyl Market Competitive Benchmarking
33. Global Fentanyl Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Fentanyl Market
35. Fentanyl Market Future Outlook and Potential Analysis
36. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Fentanyl Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
….
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Financial Performance
Table 76: Sinopharm Group Financial Performance
Table 77: Merck & Co. Inc. Financial Performance
Table 78: Bayer AG Financial Performance
Related Reports:
https://topprnews.com/self-healing-coatings-market-analysis/
https://topprnews.com/cadmium-telluride-market-report/
https://topprnews.com/corporate-learning-management-system-lms-market-growth/
https://goodprnews.com/self-healing-coatings-market-analysis/
https://goodprnews.com/cadmium-telluride-market-report/
https://goodprnews.com/corporate-learning-management-system-lms-market-growth/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
